Friday 24 September, 2021 – 09:30am – 3:30pm
At the University of Warwick Oculus Building / Hybrid
About the event:
Fuelled by the new knowledge, investment and innovation demonstrated by the UK diagnostics sector in response to Covid 19, how do we now exploit the commercial, scientific and health opportunities in diagnostics in a post-pandemic world?
This event will bring together key stakeholders from across the NHS, academia, industry and regulatory bodies to explore how we can build on the pandemic testing response to enhance cross-sector collaboration, improve the UK’s infrastructure for the development and implementation of innovative diagnostics, and build workforce capacity.
The morning session will comprise a series of keynote presentations followed by an interactive panel discussion. The afternoon session will focus on opportunities to engage with industry, how these can be developed and sustained to enable us to address public health challenges of the future.
Speakers include:
Mike Richards – NHS E/I
Doris-Ann Williams – BIVDA
Ranga Sampath – Siemens Healthineers
Mark Elliott – WMG
Karen Taylor – Deloitte
Collaborators: Warwick Health GRP, Institute of Precision Diagnostics, WMHTC
Draft programme:
9.30 Registration for in-person attendees
10.00-12.00 Keynote speakers and Q&A session
12.00-1.00 Lunch
1.00-1.45 Responding to the challenge – presentations from West Midlands Health Technology Cluster, Warwick Innovation District, Institute of Precision Diagnostics and Tissue Image Analytics (TIA) Centre
1.45-2.15 Themed break out parallel sessions – Product Development and Market Access and AI/Digital Healthcare
2.15-3.00 Final breakout session – Funding & Regional Opportunities
3.00-3.20 Keynote speaker
3.20-3.30 Closing comments
3.30-4.00 Networking
Slingshot